Northwestern Medicine investigators have discovered that inhibiting a chromatin remodeling complex associated with a particular gene in small-cell lung cancer (SCLC) cells may decrease cancer cell ...

Non-small cell lung cancer accounts for nearly 85% of all lung cancer cases. Targeted immunotherapy is a common treatment, but it does not work for everyone. However, a new Moffitt Cancer Center ...

Mar. 11, 2024 — Scientists trained a machine-learning algorithm to predict accurately brain metastasis using biopsy samples from early-stage non-small cell lung cancer patients. It was also ...

The oncolytic virus, MEM-288 will be studied in combination with Opdivo for patients with non-small cell lung cancer that ...

Non-small cell lung carcinoma (NSCLC), also called non-small cell lung cancer, is the most common type of lung cancer. “Non-small cell” refers to the way cancer cells look under a microscope.

Toward a Cure: Chemotherapy Plus TKI in EGFR-Mutant NSCLC Dr Mark Kris discusses neoadjuvant approaches for patients non-small cell lung cancer with oncogenic drivers for which there are effective ...

Big-picture patterns of DNA packaging, gene activation and mutations could hold the information needed to develop a blood-based biopsy for small cell lung cancer patients, according to new work ...

It is expected that the combination of REQORSA and Tecentriq as maintenance therapy may provide a new therapeutic option for the treatment of small cell lung cancer. Genprex has received U.S. Food ...

Lung cancer is the world’s leading cause of death due to cancer according to the World Health Organization.1 Thus an urgent ...

The US FDA Accelerated Approval of sotorasib required the sponsor to conduct a randomized trial that compared the safety and efficacy of the approved dose with a lower dose. These results ...

Research suggests that only 15pc to 30pc of people who are diagnosed with limited-stage small cell lung cancer survive for five years after diagnosis. Suresh Senan, a professor of clinical ...